Assessment of the impact of market regulation in Mali on the price of essential medicines provided through the private sector

Health Policy

Volumn 97, Issue 2-3, 2010, Pages 130-135

  Maïga, Diadié ^a,b   Williams Jones, Bryn ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Ministry of Health   (Mali)

Author keywords

Essential medicines; Mali; Market regulation; Monitoring; Pharmaceutical; Pharmacy; Private sector

Indexed keywords

ESSENTIAL DRUG; GENERIC DRUG;

ARTICLE; CONTROLLED STUDY; COST CONTROL; CROSS-SECTIONAL STUDY; DRUG COST; DRUG MARKETING; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE SURVEY; LAW ENFORCEMENT; MALI; ORGANIZATION AND MANAGEMENT; PHARMACY;

CROSS-SECTIONAL STUDIES; DRUG AND NARCOTIC CONTROL; DRUGS, ESSENTIAL; FEES, PHARMACEUTICAL; HUMANS; MALI; PRIVATE SECTOR;

EID: 77956184770     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2010.04.001     Document Type: Article

References (20)

1. Institut National de Recherche en Santé Publique. Les comptes nationaux de la santé du Mali, 1999-2004. Bamako; 2006.
2. Direction de la Pharmacie et du Médicament du Ministère de la Santé, Organisation Mondiale de la Santé Genève Surveillance et évaluation du secteur pharmaceutique national du Mali 2003, Bamako.
3. Diarra K., Coulibaly S. Financing of recurrent health costs in Mali. Health Policy & Planning 1990, 5(2):126-138.
4. Maiga D., Diawara A., Maiga M.D. Evaluation of rational prescribing and dispensing of medicines in Mali. Revue d'epidemiologie et de sante publique 2006, 54(6):497-505.
5. Cellule de Planification et de Statistique du Ministère de la Santé (CPS/MS), Direction Nationale de la Statistique et de l'Informatique du Ministère de l'Économie de l'Industrie et du Commerce, Marco International Inc. Enquête Démographique et de Santé du Mali 2006 (EDSM IV); 2007.
6. Evans RG Vendre le marché ou réglementer la régulation: qui y perd? qui y gagne? quelles attentes? quelles limites? 1996, Études de politique de santé, Organisation de Coopération et de Développement Économiques, no 8.
7. Maiga M.D., Diawara A. Study on the availability and cost of medicines in the private sector in Mali. Medecine Tropicale 2006, 66(6):565-568.
8. How to investigate drug use in Health facilities: selected drug use indicators (No. Série Recherche No 7) 1993, World Health Organization.
9. Rosner B. Fundamentals of biostatistics 2006, Thomson-Brooks/Cole, Belmont, CA. 6th ed.
10. Aaserud M., Dahlgren A.T., Kosters J.P., Oxman A.D., Ramsay C., Sturm H. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database of Systematic Reviews 2006, 2. CD005979.
11. Angell M. The truth about the drug companies: how they deceive us and what to do about it 2005, Random House Trade Paperbacks, New York, (rev. and updat. ed.).
12. Lexchin J. The pharmaceutical industry and the pursuit of profit. The power of pills: social, ethical and legal issues in drug development, marketing, and pricing 2006, 11-24. Pluto Press, London/Ann Arbor, MI. J.C. Cohen, P.M.L. Illingworth, U. Schüklenk (Eds.).
13. Olivier C., Williams-Jones B., Godard B., Mikalson B., Ozdemir V. Personalized medicine, bioethics and social refsponsibilities: re-thinking the pharmaceutical industry to remedy inequities in patient care and international health. Current Pharmacogenomics and Personalized Medicine 2008, 6(2):108-120.
14. Pang T., Gray M., Evans T. A 15th grand challenge for global public health. Lancet 2006, 367(9507):284-286.
15. The World Medicines Situation 2004, World Health Organization, Geneva.
16. Direction de la Pharmacie et du Médicament du Ministère de la Santé, Organisation Mondiale de la Santé Genève Évaluation du secteur pharmaceutique du Mali 2004, Bamako.
17. Laing R., Waning B., Gray A., Ford N., t Hoen E. 25 years of the WHO essential medicines lists: progress and challenges. Lancet 2003, 361(9370):1723-1729.
18. Report of the WHO Expert Committee on national drug policies 1995, World Health Organization, Geneva.
19. Danzon P.M., Furukawa M.F. International prices and availability of pharmaceuticals in 2005. Health Affairs 2008, 27(1):221-233.
20. Income, poverty and health insurance coverage in the United States: 2008 2009, U.S. Department of Commerce Economics and Statistics Administration U.S. CENSUS BUREAU.